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ABSTRACT
Chikungunya virus (CHIKV) is an arbovirus that emerged in the Americas in 2013. 
Infection with CHIKV is symptomatic in most of the cases and patients can develop chronic 
arthralgia that lasts from months to years in over 40% of the cases. The East-Central-South 
Africa (ECSA) genotype was introduced in Brazil in 2014, in Bahia State. Here we report 
the circulation of the CHIKV ECSA genotype in Piaui State, Northeast Brazil, during 
the years 2016-2017. The phylogenetic analysis revealed a single introduction of this 
lineage probably in 2015 and its maintenance at least until 2017. This analysis has also 
demonstrated the proximity of this genotype with isolates from neighboring States, and its 
partial nucleotide sequence of the viral E1 gene revealed a synapomorphy synonyms. This 
finding highlights the spread of the ECSA genotype in Brazil and supports its circulation 
in the Brazilian Northeast.
KEYWORDS: Chikungunya virus. Brazil. ECSA genotype. Arbovirus. Togavirus. 
Alphavirus. Molecular surveillance. Epidemiology. E1 gene.
INTRODUCTION 
Chikungunya virus (CHIKV) is an arthropod-borne, enveloped, positive single-
stranded RNA virus of the family Togaviridae, genus Alphavirus. Its genome 
contains two open reading frames encoding four nonstructural (nsP1-4) and five 
structural proteins (C, E3, E2, 6K, E1)1,2. Studies performed in Thailand, Malaysia, 
Mayotte and La Reunion islands have shown that 52 to 98% of the infected patients 
develop symptoms that range from fever, headache, myalgia, articular edema and 
rash to intense polyarthralgia and severe joint pain3-6. Furthermore, a variety of 
studies have reported a high prevalence of chronic arthralgia, which can last from 
months to years in approximately 40% of the infected people7,8.
CHIKV was isolated for the first time in 1952-53 in Tanzania9. So far, four 
distinct lineages have been recognized: East-Central-South Africa (ECSA), Indian 
Ocean (IOL), Asian and West African lineages10. Until 2004, CHIKV had caused 
small and sporadic outbreaks at the African and Asian continents, however that 
year, the ECSA genotype caused massive outbreaks in the East Africa coast11,12. 
This was followed by unprecedent epidemics in Indian Ocean islands and Asia as 
well as the first outbreak in a temperate region in Italy13. In 2013, the first cases of 
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autochthonous transmission in the Americas were reported 
in the Caribbean island of Saint Martin, caused by the 
Asian genotype14. In late 2014, the Asian genotype was 
detected in the Amapa State, Northern Brazil15, whereas 
the ECSA genotype was later detected in Bahia State, 
Northeast Brazil16. According to the Brazilian Ministry of 
Health, between 2016 and 2018, 547,797 suggestive cases 
of CHIKV were reported in the country, with 361,640 
laboratory confirmed cases and 387 CHIKV-associated 
deaths17-19. The Northeast region of the country accounted 
for 86.4% and 76,8% of the suggestive cases during 2016 
and 2017, respectively17,19.
Piaui State (PI) is located in the Northeast region 
of Brazil, and borders the States of Bahia, Ceara, 
Pernambuco and Maranhao and Tocantins (Figure 1). Until 
2016, no cases of CHIKV (imported or autochthonous) 
were reported in Piaui State. However, in 2016, the 
incidence rate of suggestive CHIKV infections increased 
to 86.4 per 100.000 inhabitants, the lowest in the 
Northeast region19, and peaked in 2017 reaching 194.5 per 
100.000 inhabitants17. In 2018, the incidence rate dropped 
to 17.4 per 100.000 inhabitants. In addition, deaths caused 
by CHIKV infection have been confirmed in Piaui State 
in 2016 and 201717,18. Considering that there has been an 
increase in the incidence rate of CHIKV in Piaui State, the 
aim of the present study was to investigate and to identify 
the circulating genotype in the State.
MATERIALS AND METHODS
Clinical samples and ethical statement
From April 2016 to November 2017, clinical samples 
were collected at the Urgency Medical Service Unity and 
State Hospital Dirceu Arcoverde in the city of Parnaiba, 
Piaui State, Brazil. Serum were obtained from whole 
blood samples collected from patients presenting two 
or more of the following symptoms: fever (>38.5 °C), 
headache, arthralgia, myalgia, rash and/or hemorrhagic 
manifestations. Informed consent was obtained from all the 
patients or their legal guardians, and a form with questions 
about age, days of symptoms, travel history and previous 
diagnostics was filled out. The collected samples were 
stored at 4 °C, transported to the research laboratory at the 
Federal University of Piaui within 5 h after collection and 
stored at -70 °C. When available, results of the serological 
tests for DENV and CHIKV performed by public health 
services were retrieved. The research was approved by the 
Human and Ethics Committee of the Federal University of 
Piaui, under the protocol Nº CAAE 46111615.0.0000.5214.
Molecular investigation of Chikungunya infection
Viral RNA extractions were performed from serum 
of patients presenting three or more symptoms, less than 
Figure 1 - The geographic location of Piaui State in Brazil. Teresina and Parnaiba municipalities are highlighted in blue and orange, 
respectively. BA: Bahia; CE: Ceara; MA: Maranhao; PE: Pernambuco; PI: Piaui TO: Tocantins.
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5 days of the onset of symptoms and the presence of IgM 
antibodies against CHIKV, when available. The viral RNA 
extraction was perfomed using QIAamp viral RNA Mini 
Kit (Qiagen, Hilden, Germany) or NucleoSpin® RNA 
Virus (Macherey-Nagel, Düren, Germany), following the 
manufacturer’s instructions.
The cDNA synthesis was carried with random hexamers 
(20 µM, Qiagen, Hilden, Germany) and Moloney Murine 
Leukemia virus reverse transcriptase (Promega, Madison, 
Wisconsin, USA), following the manufacturer’s instructions. 
Using specific primers previously described for CHIKV E1 
(DVRChk-F 5’ ACCGGCGTCTACCCATT CATGT 3’; 
DVRChk-R 5’ GGGCGGGTAGTCCATGTTGTAGA 3’)20 
and CHIKV E2 (JM1 5’ GCAGACGCAGAGAGGGCCAG 
3’;  JM2 5’ CGTGCTGCAAGGTAGTTCTC 3’; 
JM3 5’ GCTATTTGTAAGAACGTCAG 3’; JM4 
5’TACCGTGCTGCGGTCGGGA A 3’)21 genes, partial 
genome sequences were amplified. The expected products 
of 330 bp (E1) and 240 bp (E2) were separated by 
electrophoresis in 1.5% agarose gels stained with the 
intercalant agent GelRed™ (Biotium Inc., Freemont, 
California, USA) and visualized under U.V. lights. The 
expected bands were excised from the gel and purified 
using the QIAQuick Gel Extraction Kit (Qiagen, Hilden, 
Germany) for nucleotide sequencing.
Nucleotide sequencing and phylogenetic analysis
PCR amplicons of the E1 and E2 genes were sequenced 
using 0.5 uM of each specific primer (forward and reverse) 
and approximately 10 ng of each DNA sample. The 
sequencing was performed in a ABI 3130 DNA Analyzer 
(Applied Biosystems) using BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems), using the Sanger 
sequencing platform of Rene Rachou Institute (Fiocruz, 
Minas Gerais, Brazil). Raw data were analyzed and final 
contigs were assembled using the Geneious R9 version 
9.1.822. The partial sequences of E2 and E1 genes were 
concatenated in frame and aligned to 74 concatenated 
sequences of CHIKV genotypes retrieved from GenBank 
(http://www.ncbi.nlm.nih.gov) using CLUSTALW, 
implemented on MEGA623. The nucleotide substitution 
model of Kimura 2-parameters with Gamma distribution 
(4 categories) (K2+G) was selected using jModelTest 
v 2.1.424. The maximum likelihood tree was reconstructed 
using MEGA 623 with a total of 88 sequences, the nucleotide 
substitution model K2+G with 1000 bootstrap replicates.
Bayesian inferences were performed using BEAST 
package 1.8.425 with Markov Chain Monte Carlo algorithms 
(MCMC). Input files for BEAST v.1.8.4 were created with 
BEAUTi v.1.8.426, using 88 concatenated E2E1 sequences. 
The best model was selected comparing the marginal 
likelihood estimations (MLE)27. The estimates were 
performed using the nucleotide substitution model GTR, 
with gamma distribution (four categories), under the relaxed 
molecular clock and the Bayesian skyline demographic 
Model. Three hundred million chains were run, the first 
30 million steps were discarded, and convergence of 
parameters was verified with Tracer v.1.5.028. The trees 
were sampled at every 10,000 steps and then summarized 
in a maximum clade credibility tree using TreeAnnotator 
v.1.8.229. The final tree was visualized in FigTree v.1.4.330.
RESULTS
Clinical samples and serological results
During April/2016 and November/2017, 580 patient 
samples were collected. 40.2% (233/580) of samples 
were collected during 2016, whereas 59.8% (347/580) 
were collected during 2017. The majority of the patients 
were woman (66.4%). The main clinical signs were fever 
(84.65%), arthralgia (82.06%), headache (77.75%) and 
myalgia (71.38%) (Table 1). However, 0.86% (5/580) of 
patients have also presented neurological complications, 
such as encephalitis. Of the 580 samples collected, 
serological tests for CHIKV IgM were performed on 
52.59% (305/580) samples, CHIKV IgG on 19.31% 
(112/580), DENV IgM on 75.69% (439/580) and DENV 
IgG on 61.72% (358/580). Of these, 70.16% (214/305) were 
positive for CHIKV IgM, 14.12% (62/439) for DENV IgM 
and 36 (6.21%) were positive for both CHIKV and DENV 
IgM tests (Figure 2).
RT-PCR for CHIKV
From the total of collected samples, RNA extraction 
were performed on 19.31% (112/580) samples. Of these, 
56.25% (63/112) were from 2016 and 43.75% (49/112) 
from 2017. Of the analyzed samples, 29.46% (33/112) 
were positive for CHIKV by PCR, with 57.58% (19/33) 
from 2016 and 42.42% (14/33) from 2017. Of the positive 
samples, CHIKV specific IgM tests were available for 
36.36% (12/33) patients, of which 50% (6/12) were CHIKV 
IgM positive (Figure 2). 87.88% (29/33) of the PCR-
positive CHIKV samples had DENV IgM tests performed, 
and 10.34% (3/29) of samples were positive. Only one of 
the CHIKV-positive samples with serological tests results 
presented both DENV and CHIKV IgM antibodies. Of 
the 33 CHIKV-positive samples, one (3.03%) patient 
of 11 years old presented clinical signs of encephalitis 
as well as fever, vomiting, headache, myalgia and eye 
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complications. The presence of CHIKV IgM antibodies 
was detected in this sample, but DENV IgM and IgG were 
not detected. Among the PCR negative samples (79/112), 
CHIKV IgM tests were performed on 39.34% (31/79) of the 
patients. Of these, 70.97% (22/31) of the samples presented 
CHIKV IgM antibodies (Figure 2).
Figure 2 - Flowchart showing the total number of patient samples collected and laboratory tested (RT-PCR) to CHIKV during 
April/2016 to November/2017.
Table 1 - Demographic and clinical characteristics of suspected cases of CHIKV infection during April/2016 to November/2017 in 
Piaui, Brazil, according to CHIKV laboratory test results (RT-PCR).
 
All Samples 
(n=580)
Suspected 
cases (n=112)
Positive 
(n=33)
Negative 
(n=79)
Sequenced 
(CHIKV ECSA) 
(n=14)
Sex  
 Female 66.4% 62.5% 54.55% 65.82% 57.14%
Age (years)  
Median(range) 33(1-89) 29(3-85) 35(6-85) 27(3-76) 37(7-73)
Clinical Symptoms
Fever 84.65% 85.71% 93.94% 81.01% 100%
Arthralgia 82.06% 82.14% 90.91% 78.48% 92.86%
Headache 77.75% 74.11% 81.82% 69.62% 92.86%
Myalgia 71.38% 66.96% 75.76% 63.29% 100%
Exanthema 63.79% 66.07% 57.57% 69.62% 71.43%
Prostration 54.14% 56.25% 48.48% 59.49% 57.14%
Eye problems 52.07% 52.68% 45.45% 55.70% 42.86%
Nauseas 48.02% 42.86% 54.54% 37.98% 57.14%
Vomits 25.52% 26.78% 21.21% 27.89% 28.57%
Articular Edema 23.45% 25.89% 39.39% 20.25% 57.14%
Diarrhea 18.79% 16.94% 12.12% 18.99% 14.29%
 Neurological Complications 0.86% 4.46% 3.03% 5.06% 7.14%
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Nucleotide sequencing and phylogenetic analysis
The partial sequence of E2 and E1 genes of 14 samples 
from 2016 and 2017 were determined (GenBank accession 
Nº MK510154-MK510181). The partial sequences of E2 
(208 nt) and E1 (120 nt) genes were concatenated in frame 
(328 nt; corresponding to positions 8,804 to 8,923 and 
10,253 to 10,460 compared to the nucleotide sequence 
of CHIKV strain BHI3745/H804709, isolated in Feira de 
Santana, Bahia (GenBank accession Nº KP164570). The 
phylogenetic analysis based on the Maximum likelihood 
(Supplemental Figure 1) and Bayesian methods revealed 
that all sequenced isolates belonged to the ECSA genotype 
and clustered together, forming a monophyletic group, 
called CHIKV/PI/2016-2017 (supported by a posterior 
probability (PP) equal to 0.96). This group clustered with 
other CHIKV isolates, circulating from 2014 to 2016, in 
Bahia16, Rio de Janeiro31, Sergipe32, Alagoas33, Paraiba and 
Pernambuco (PP=1) (Figure 3). 
The isolates from CHIKV/PI/2016-2017 had the most 
recent common ancestor (MRCA) estimated in 2015 (95% 
Bayesian credible interval = 2014 to 2016). The nucleotide 
sequences within CHIKV/PI/2016-2017 were identical to 
each other. When sequences within CHIKV/PI/2016-2017 
were compared to sequences from other Brazilian isolates 
(collected during 2014-2016), a nucleotide similarity of 
99.3% was observed. Analysis of nucleotide and predicted 
amino acid sequences of CHIKV/PI/2016-2017 compared 
to sequences belonging to others Brazilian CHIKV/
ECSA genotypes, indicated a synonymous nt substitution 
characterized as synapomorphy (position 87 of the E1 gene 
of CHIKV/PI/2016-2017 sequences). 
Figure 3 - Bayesian phylogenetic analysis of Chikungunya virus. A subtree of the ECSA genotype, from the maximum clade credibility 
tree inferred using 88 Chikungunya virus sequences (328 nt) is shown. The posterior probability values are represented by circles 
drawn in scale in the nodes. Clades containing strains from Piaui (2016/2017) and the Indian Ocean Lineage are shown in red and 
blue, respectively. Branch lengths are drawn to scale of years. The tree was reconstructed using the nucleotide substitution model 
GTR with gamma distribution (four categories), under the relaxed molecular clock and the Bayesian skyline demographic model. 
PI: Piaui. BR: Brazil. GECSA: Genotype East-Central South African. CHIKV: Chikungunya virus.
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DISCUSSION
In this study, we performed a molecular investigation 
of CHIKV infection in symptomatic patients in Piaui State, 
Northeast Brazil, during 2016 and 2017. By using molecular 
tests, CHIKV infections were confirmed in 33 patients out 
of 112 tested samples. As the presence of acute symptoms 
such as fever, arthralgia, myalgia and headache lasting less 
than 5 days after the onset of the symptoms was a criterion 
of inclusion, our symptoms data should be carefully 
considered. However, it is noteworthy to add that one of 
the CHIKV-positive patients developed encephalitis, the 
most common neurological complication reported during 
outbreaks in La Reunion34, Guadeloupe and Martinique35 
islands.
It is difficult to estimate the incidence of neurological 
symptoms among infected pat ients ,  however, 
encephalopathies are the most common neurological 
disorders associated with CHIKV infection36. On the other 
hand, symptoms such as fever, arthralgia, headache and 
myalgia are better described in CHIKV infected patients. 
These symptoms were the most prevalent in our positive 
samples, and were also observed in patients from Alagoas33 
and Sergipe37 States, Northeast Brazil.
After the partial nucleotide sequencing of E1 and E2 
genes, phylogenetic analysis indicated that the Piaui CHIKV 
isolates presented in this study were clustered within the 
ECSA genotype and formed a monophyletic clade with 
other Brazilian samples from 2014 to 2016. Based on the 
evolutionary analysis, our extracted viral RNAs share the 
most common recent ancestor dating from 2015, suggesting 
the introduction of CHIKV ECSA genotype into Piaui 
probably in that year. Studies performed in Pernambuco38 
and Alagoas33 States, also located in the Brazilian Northeast 
region, have suggested that CHIKV was also introduced in 
these States in 2015. 
Moreover, the interval between the introduction 
of CHIKV in Piaui in 2015, and the report of its 
detection made only in 2016 by the surveillance system, 
demonstrated a silent circulation and maintenance of the 
virus in the region18,39. These data corroborate the finding 
from Costa et al.33, who estimated the introduction of 
CHIKV in Alagoas in mid-April 2015, but the virus was 
detected by the surveillance system a few months later33. 
Furthermore, a recent study on isolates from Rio de 
Janeiro, Southeast Brazil, has shown that the introduction 
of CHIKV ECSA genotype in the State may have taken 
place almost a year after its detection by the surveillance 
system40. Altogether, these data corroborate our finding 
that CHIKV may have been circulating in Piaui up to a 
year before its detection.
CONCLUSION
In conclusion, we provided the first genotype surveillance 
of CHIKV cases during 2016/2017 in Piaui State, Northeast 
Brazil. Our study corroborates the circulation of the ECSA 
genotype in other Brazilian Northeastern States during this 
period, such as Bahia41, Sergipe32 and Alagoas33,42. Our data 
also indicate the introduction of CHIKV in Piaui in 2015, 
and its maintenance up to 2017. Since previous studies have 
shown a high incidence of chronic symptoms7,8, which could 
have social and economic impacts, more research is needed 
to evaluate the prevalence and impact of acute and chronic 
CHIKV infections in the region.
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Supplemental Figure 1 - Maximum likelihood analysis of Chikungunya virus. The maximum likelihood tree was inferred using 
88 Chikungunya virus sequences (328 nt). The bootstrap values are represented by circles drawn in scale in the nodes. Clades 
containing strains from Piaui (2016/2017), and Indian Ocean Lineage are shown in red and blue, respectively. Branch lengths are 
drawn to scale or the number of substitutions per site. The tree was reconstructed using the nucleotide substitution model Kimura- 
2-parametrers with gamma distribution (four categories) (K2+G). PI: Piaui State. GECSA: Genotype East-Central South African. 
Gwest African: Genotype West African. GAsian: Genotype Asian. CHIKV: Chikungunya virus.
